Industrial and Clinical Laboratory Products
or
Search options
Home > Categories > Invitrogen
Invitrogen
-
-
-
( 3191 )
-
-
-
( 68 )
-
-
-
( 58 )
- View All
-
-
-
( 3191 )
-
-
-
( 68 )
-
-
-
( 58 )
-
( 130 )
-
-
-
( 457 )
-
( 99 )
-
-
( 95 )
-
( 5691 )
-
( 6 )
-
( 1 )
-
-
( 24 )
-
( 7 )
-
( 105 )
-
-
( 12 )
-
( 182 )
-
( 2 )
-
( 1 )
-
-
( 2 )
-
-
-
-
( 2894 )
-
( 300 )
-
( 123 )
-
( 49 )
-
( 252 )
-
( 157 )
-
( 13 )
-
-
-
-
( 79 )
-
( 20 )
-
( 132 )
-
( 48258 )
-
( 21 )
-
-
( 4 )
-
-
( 256 )
-
-
( 199 )
-
-
( 2 )
-
( 269 )
-
-
-
-
( 4 )
-
-
-
-
( 92 )
-
( 21 )
-
( 1907 )
-
-
( 83 )
-
( 146 )
-
( 194 )
-
-
-
-
( 5 )
-
( 1 )
-
( 14 )
-
-
( 2489 )
-
-
-
( 3 )
-
-
( 403 )
-
( 9 )
-
-
( 1174 )
-
( 30 )
-
-
( 4 )
-
( 20 )
-
( 68 )
-
( 15 )
-
-
-
-
( 74 )
-
-
-
-
( 157 )
-
( 119 )
-
-
-
-
( 35 )
-
( 140 )
-
( 53 )
-
( 120 )
-
( 6 )
-
( 110 )
-
( 42 )
-
( 69 )
-
-
( 23210 )
-
( 5 )
-
-
-
-
-
( 39 )
-
( 19270 )
-
( 3651 )
-
-
( 289 )
-
-
( 1 )
-
-
-
( 8 )
-
( 373 )
-
-
-
-
( 833 )
-
-
( 134 )
-
( 279 )
-
( 1 )
-
( 182 )
-
-
( 2499 )
-
-
( 167 )
-
-
( 12 )
-
-
( 2 )
-
-
-
-
-
( 7 )
-
-
( 6 )
-
( 131 )
-
( 232 )
-
( 81 )
-
-
-
( 150 )
-
( 370 )
-
-
-
-
( 1 )
-
( 3 )
-
( 11536 )
-
( 109 )
-
( 902 )
-
( 68 )
-
( 22 )
-
( 3 )
-
( 2 )
-
-
-
-
( 175 )
-
( 104 )
-
( 486 )
-
-
( 240 )
-
( 28 )
-
-
( 104 )
-
( 108 )
-
-
-
-
( 8 )
-
( 27 )
-
( 26 )
-
( 33 )
-
( 11 )
-
-
( 229 )
-
-
-
( 180 )
-
-
( 4 )
-
-
-
-
-
-
( 306 )
-
( 22 )
-
( 112 )
-
-
( 1 )
-
( 27 )
-
( 28 )
-
( 2 )
-
( 63 )
-
-
( 160 )
-
-
( 683 )
-
-
( 2 )
-
( 19 )
-
( 13 )
-
-
( 21 )
-
( 5 )
-
( 27 )
-
( 7 )
-
( 1 )
-
( 28 )
-
( 380 )
-
-
-
( 86 )
-
( 9 )
-
( 52 )
-
-
( 25 )
-
( 13 )
-
( 1 )
-
-
( 8 )
-
( 126 )
-
( 19 )
-
( 86 )
-
( 8149 )
-
( 15 )
-
( 11 )
-
-
( 1 )
-
-
( 1 )
-
-
( 24 )
-
( 13787 )
-
( 446 )
-
-
( 370 )
-
( 19 )
-
( 77 )
-
( 91 )
-
-
( 310 )
-
( 979 )
-
-
-
( 115 )
-
-
( 12 )
-
-
-
-
( 2 )
-
-
-
( 88 )
-
-
( 120 )
-
( 1613 )
-
( 1 )
-
( 98 )
-
( 9 )
-
( 12 )
-
-
( 28 )
-
-
( 29 )
-
-
-
( 2 )
-
-
-
-
( 15 )
-
( 7 )
-
( 4 )
-
( 93 )
-
-
( 9 )
-
( 7 )
-
( 1 )
-
( 250 )
-
( 169 )
-
-
-
-
( 86 )
-
-
( 51 )
-
-
( 200 )
-
( 53 )
-
-
( 4 )
-
( 443 )
-
-
-
-
( 9 )
-
( 27 )
-
-
( 26 )
-
-
( 2 )
-
-
( 1 )
-
-
( 50 )
-
-
( 45 )
-
( 35 )
-
( 297 )
-
( 20 )
-
( 419 )
-
( 1427 )
-
-
-
( 116 )
-
( 5858 )
-
( 1696 )
-
( 62 )
-
-
( 46 )
-
( 275 )
-
-
( 159 )
-
( 6 )
-
( 4 )
-
( 91 )
-
-
( 112 )
-
( 1 )
-
-
( 14 )
-
( 11 )
-
-
( 87 )
-
-
( 61 )
-
-
( 3 )
-
-
( 16431 )
-
-
-
-
( 4 )
-
-
( 58 )
-
( 57 )
-
( 73 )
-
( 2559 )
-
( 15 )
-
-
( 4 )
-
( 1765 )
-
( 7 )
-
-
( 106 )
-
-
-
( 68 )
-
( 279 )
-
-
( 96 )
-
( 2 )
-
-
( 489 )
-
( 15 )
-
-
-
-
-
( 496 )
-
-
( 7 )
-
-
-
-
( 107 )
-
-
-
-
( 68 )
-
-
( 19 )
-
-
( 1 )
-
( 83 )
-
-
( 57 )
-
-
( 166 )
-
( 26 )
-
( 3 )
-
-
( 11372 )
-
-
-
( 185 )
-
( 4 )
-
-
-
( 100 )
-
-
( 2 )
-
( 24 )
-
-
( 143 )
-
-
( 13 )
-
( 46 )
-
-
-
( 3 )
-
( 13 )
-
-
-
( 11 )
-
( 509 )
-
-
-
( 8 )
-
-
-
( 462 )
-
( 1 )
-
-
-
( 221 )
-
-
( 17 )
-
( 92 )
-
-
-
-
-
-
( 138 )
-
-
-
( 5 )
-
-
( 580 )
-
( 99 )
-
( 578 )
-
( 4381 )
-
-
-
( 237 )
-
( 48 )
-
( 94 )
-
-
( 4 )
-
( 1659 )
-
-
( 2 )
-
( 49 )
-
( 17 )
-
( 488 )
-
( 538 )
-
-
-
( 71 )
-
( 122 )
-
( 142 )
-
( 335 )
-
( 23 )
-
-
( 1 )
-
( 211 )
-
( 3 )
-
-
( 97 )
-
-
-
-
( 6 )
-
( 4 )
-
( 147 )
-
( 3 )
-
-
-
( 846 )
-
( 111 )
-
( 617 )
-
( 4 )
-
-
-
( 18 )
-
( 51 )
-
-
( 2 )
-
-
( 139 )
-
( 144 )
-
( 593 )
-
( 55 )
-
-
( 2 )
-
-
-
-
-
( 3255 )
-
-
( 326 )
-
( 262 )
-
( 116 )
-
-
-
-
-
( 160 )
-
-
( 18 )
-
-
( 15 )
-
( 16 )
-
-
( 9 )
-
( 197 )
-
( 1 )
-
( 537 )
-
( 334 )
-
-
( 56 )
-
-
-
( 4 )
-
( 617 )
-
( 55 )
-
( 3 )
-
-
-
( 357 )
-
-
-
( 2 )
-
( 7 )
-
-
( 3 )
-
( 9 )
-
( 635 )
-
-
( 69 )
-
( 2 )
-
( 8 )
-
( 52 )
-
( 4229 )
-
( 61 )
-
-
-
( 25 )
-
( 267 )
-
-
-
( 111 )
-
( 764 )
-
( 5 )
-
( 17 )
-
( 2 )
-
( 544 )
-
( 26 )
-
( 193 )
-
-
-
-
( 707 )
-
( 1 )
-
-
( 7 )
-
( 5 )
-
( 2 )
-
( 288 )
-
( 14 )
-
( 32 )
-
( 1 )
-
-
( 17 )
-
-
-
( 86 )
-
( 855 )
-
-
( 4 )
-
( 742 )
-
-
( 79 )
-
( 143 )
-
-
( 34 )
-
( 33 )
-
( 1881 )
-
-
-
-
-
( 1335 )
-
-
-
-
( 1092 )
-
( 1069 )
-
-
( 76 )
-
( 1742 )
-
( 307 )
-
-
-
-
( 44 )
-
( 44 )
-
( 27 )
-
( 322 )
-
( 14 )
-
( 34 )
-
-
( 130 )
-
( 24 )
-
-
-
( 4 )
-
( 2078 )
-
( 7874 )
-
-
( 2334 )
-
( 252 )
-
-
( 84 )
-
( 39 )
-
-
-
( 163 )
-
-
-
-
-
( 120 )
-
( 7 )
-
-
-
( 49 )
-
-
( 3 )
-
( 235 )
-
( 29 )
-
( 1746 )
-
-
( 1 )
-
( 439 )
-
-
( 66 )
-
-
-
( 5 )
-
( 78 )
-
-
-
-
( 2 )
-
-
-
-
-
( 12 )
-
( 23 )
-
-
( 702 )
-
-
( 2 )
-
-
( 2 )
-
( 54 )
-
-
-
( 8 )
-
( 33 )
-
( 33 )
-
-
( 24 )
-
( 1632 )
-
( 329 )
-
-
-
-
-
-
-
( 1059 )
-
-
-
( 663 )
-
-
( 25 )
-
( 58 )
-
( 172 )
-
-
( 20 )
-
( 259 )
-
( 1 )
-
( 1 )
-
( 20 )
-
( 16 )
-
( 546 )
-
( 62 )
-
( 49 )
-
-
( 162 )
-
( 36 )
-
( 42 )
-
-
( 2 )
-
( 54 )
-
-
-
( 19 )
-
( 2011 )
-
-
( 829 )
-
( 162 )
-
( 53 )
-
( 1444 )
-
( 508 )
-
( 6 )
-
( 1 )
-
( 10 )
-
( 329 )
-
-
-
( 343 )
-
-
-
-
-
( 1 )
-
-
( 16851 )
-
( 1 )
-
( 530 )
-
( 142 )
-
-
-
( 105 )
-
-
( 299 )
-
( 4 )
-
-
( 27 )
-
( 107 )
-
( 1757 )
-
-
-
( 3033 )
-
( 16 )
-
( 9 )
-
( 3 )
-
-
-
( 143 )
-
( 2836 )
-
( 5 )
-
-
( 110 )
-
( 2999 )
-
( 9 )
-
( 20 )
-
-
-
-
-
( 41 )
-
( 2401 )
-
( 930 )
-
-
-
( 52 )
-
( 162 )
-
( 117 )
-
-
( 16 )
-
( 2 )
-
-
-
-
-
( 10 )
-
( 5 )
-
-
( 20 )
-
( 519 )
-
( 4609 )
-
( 2 )
-
( 34 )
-
-
-
( 2 )
-
( 10 )
-
-
( 236 )
-
( 36 )
-
( 2073 )
-
-
( 23 )
-
( 152 )
-
( 4 )
-
( 2 )
-
( 2 )
-
( 22 )
-
( 241 )
-
-
-
( 181 )
-
( 739 )
-
-
-
( 35 )
-
-
-
-
( 17 )
-
( 23 )
-
-
-
( 20038 )
-
( 21 )
-
-
( 188 )
-
-
( 124 )
-
( 109 )
-
-
( 23 )
-
-
( 20 )
-
-
( 4 )
-
-
-
( 4 )
-
-
-
-
( 12 )
-
( 13 )
-
( 17 )
-
( 76 )
-
( 25 )
-
-
( 33 )
-
( 109 )
-
-
-
( 3 )
-
-
-
-
( 5 )
-
-
-
-
( 134 )
-
( 113923 )
-
( 4 )
-
( 9 )
-
( 45 )
-
-
-
-
( 1 )
-
-
( 4 )
-
( 588 )
-
-
( 67 )
-
-
( 36 )
-
( 23 )
-
-
( 274 )
-
( 2 )
-
( 103 )
-
( 6 )
-
-
-
( 39 )
-
( 33 )
-
( 38 )
-
( 10 )
-
-
( 2 )
-
-
( 156 )
-
( 33 )
-
-
-
( 1804 )
-
( 9 )
-
-
( 2059 )
-
( 11 )
-
-
-
-
( 72 )
-
-
( 19 )
-
-
( 195 )
-
( 97 )
-
( 1704 )
-
( 2 )
-
( 1 )
-
( 1 )
-
( 2834 )
-
-
( 13 )
-
-
-
( 198 )
-
-
( 58242 )
-
-
( 274 )
-
-
( 1 )
-
-
( 40 )
-
( 74 )
-
-
-
( 18 )
-
-
( 1148 )
-
-
( 303 )
-
( 6 )
-
( 1 )
-
-
( 10591 )
-
( 2 )
-
-
-
-
( 12 )
-
( 6584 )
-
-
( 32 )
-
-
-
( 77 )
-
-
-
( 139 )
-
-
( 181 )
-
-
( 128 )
-
( 1 )
-
( 7 )
-
( 1075 )
-
-
-
-
-
-
( 187 )
-
( 281 )
-
( 1 )
-
-
-
-
( 3272 )
-
( 162 )
-
-
( 173 )
-
( 32 )
-
( 24 )
-
( 1 )
-
( 80 )
-
-
( 1 )
-
-
-
( 40 )
-
-
( 129 )
-
-
( 171 )
-
( 12 )
-
( 24 )
-
( 24 )
-
( 126 )
-
( 3 )
-
( 3 )
-
( 57 )
-
( 1 )
-
-
( 7 )
-
( 104 )
-
-
-
-
( 4 )
-
-
( 249 )
-
-
-
-
( 615 )
-
( 420 )
-
-
-
( 2255 )
-
( 6 )
-
( 1586 )
-
-
( 6 )
-
( 87 )
-
-
-
-
-
( 42 )
-
-
-
( 296 )
-
( 110 )
-
-
( 433 )
-
-
( 1326 )
-
( 33 )
-
-
-
( 571 )
-
( 3 )
-
-
( 18719 )
-
( 127 )
-
( 1 )
-
-
( 41 )
-
( 1 )
-
-
( 997 )
-
( 1 )
-
-
( 25 )
-
( 4864 )
-
-
-
( 31 )
-
( 374 )
-
-
-
-
-
( 33 )
-
( 122 )
-
( 1596 )
-
( 5 )
-
-
-
( 61 )
-
( 51 )
-
( 414 )
-
( 5809 )
-
( 364 )
-
( 271 )
-
( 30 )
-
-
( 114 )
-
-
( 209 )
-
( 189 )
-
-
( 1 )
-
-
( 170 )
-
-
-
-
-
( 12 )
-
-
( 4 )
-
( 6 )
-
( 1071 )
-
-
( 1 )
-
( 110 )
-
( 132 )
-
( 1 )
-
( 25 )
-
-
-
( 133 )
-
-
-
( 2 )
-
( 91 )
-
( 50 )
-
( 31 )
-
( 1 )
-
( 75 )
-
( 1340 )
-
-
( 8058 )
-
( 81 )
-
( 8 )
-
-
-
-
-
( 131 )
-
-
( 1 )
-
( 4 )
-
-
( 7 )
-
( 303 )
-
( 1150 )
-
( 649 )
-
( 11 )
-
( 57 )
-
-
( 59 )
-
( 416 )
-
( 134 )
-
( 1 )
-
-
-
( 21 )
-
-
-
( 231 )
-
( 154 )
-
-
( 32 )
-
-
-
( 122 )
-
( 49 )
-
-
( 52 )
-
( 133 )
-
-
( 399 )
-
( 1 )
-
( 299 )
-
-
-
-
( 373 )
-
( 463 )
-
-
( 4 )
-
( 100 )
-
-
-
( 30 )
-
( 13 )
-
-
-
( 21 )
-
-
-
( 2 )
-
-
( 24 )
-
-
-
-
-
( 4 )
-
-
( 44 )
-
-
( 4 )
-
( 98 )
-
( 1553 )
-
( 28 )
-
-
-
-
( 147 )
-
-
( 192 )
-
( 1 )
-
( 1 )
-
( 6 )
-
( 284 )
-
( 111 )
-
( 13 )
-
( 6 )
-
( 6 )
-
-
( 112 )
-
-
( 232 )
-
( 8 )
-
-
-
( 1536 )
-
-
-
( 12 )
-
( 17 )
-
-
( 2 )
-
( 150 )
-
-
( 25 )
-
( 6 )
-
( 2 )
-
-
-
( 5 )
-
( 184 )
-
( 1 )
-
( 3 )
-
( 135 )
-
-
-
( 14 )
-
-
( 9 )
-
-
( 62 )
-
( 467 )
-
-
-
( 2 )
-
-
( 617 )
-
( 1371 )
-
( 279 )
-
( 155 )
-
( 3 )
-
( 1428 )
-
-
( 149 )
-
( 2 )
-
-
-
-
-
( 902 )
-
( 5 )
-
( 1 )
-
( 3 )
-
-
-
-
-
-
( 73 )
-
( 233 )
-
( 4 )
-
( 21 )
-
( 142 )
-
( 1188 )
-
-
( 1 )
-
-
( 2291 )
-
( 112 )
-
- Hide
|
MICTSTSTR CR 0.016-256 30/PKRX |
Liofilchem MTS Cefpirome [CR] 0.016-256 ug/mL, Quantity: 30/Pack, Packaging: Individually Packed, For Use With: For determining the MIC of antimicrobial agents against microorganisms, MIC Test Strip, Storage Requirements: -20 deg.C or 2-8 deg.C until the
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
MICTSTSTR NET 0.016-256 10PKRX |
Liofilchem MTS Netilmicin [NET] 0.016-256 ug/mL, Quantity: 10/Pack, Packaging: Individually Packed, For Use With: For determining the MIC of antimicrobial agents against microorganisms, MIC Test Strip, Storage Requirements: -20 deg.C or 2-8 deg.C until th
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ANTI-FC EPSILON R1 ALPHA MONOC |
FceR1 alpha, Host Species: Mouse, Target Species: Human, Shrew, Monoclonal, Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Clone: CRA1 (aeR37), Primary, 1 mg/mL, Unconjugated, 100 ug, Liquid, PBS with
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ANTI-FC EPSILON R1 ALPHA MONOC |
FceR1 alpha, Host Species: Mouse, Target Species: Human, Monoclonal, Immunohistochemistry (Frozen), Immunohistochemistry (Paraffin), Flow Cytometry, Western Blot, Clone: CRA2 (aeR24), Primary, 1 mg/mL, Unconjugated, 100 ug, Liquid, PBS with 50% glycerol a
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
MOUSE IGM ISOTYPE CONTROL |
Mouse IgM, Host Species: Murine, Target Species: Not Applicable, ELISA, Control, 1mg/mL, Unconjugated, Liquid, PBS with 0.1% sodium azide; pH 7.4, IgM, IgM mu, Purified, RUO, Avoid Freeze/Thaw Cycles, Store at -20 deg.C, Isotype Control
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DYNABEADS PAN MOUSE IGG |
Invitrogen Dynabeads Pan Mouse IgG, Quantity: 5 x 5mL, Antibody Fragment: Whole Antibody, Capacity: Processes ~2x10^9 cells total, Cell Type: All cells from all species, except mouse, Clonality: Monoclonal
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DYNABEADS CD31 ENDOTHELIAL |
Invitrogen Dynabeads CD31 Endothelial Cell, Capacity: Processes ~2x10^9 cells total, Cell Type: Endothelial Cells, Content And Storage: This Product Contains: 5 ml Dynabeads coated with anti-CD31 monoclonal antibody. Store at 2-8 deg.C, Isolation Techn
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DYNABEADS M-280 STREPTAVIDIN |
Invitrogen Dynabeads M-280 Streptavidin, Quantity: 10mL, Binding Property: 650-900 pmoles/mg beads, Concentration: 10 mgml, 10 mg/mL
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
DYNABEADS MOUSE CD43 (B CELLS) |
Invitrogen Dynabeads Mouse CD43 (Untouched B Cells), Capacity: Processes ~2x10^9 cellskit, Processes ~2x10^9 cells total, Processes ~1x10^9 cellskit, Cell Type: B Cells
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
COVID-19 POSITIVE RED |
Covid-19 Positive Red
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Categories
- Antibodies
- Boxes & Packaging
- Cannabis Solutions
- Chemicals
- Chromatography
- Clinical
- Cryogenic Supplies
- Custom Kits
- Cytology
- DNA Supplies
- Equipment
- Facilities Maintenance
- Filtration
- Furniture
- Glassware
- Hematology
- Histology
- Immunology
- Janitorial
- Lab Supplies And Equipment
- Lagasse
- Material Handling
- Microbiology
- Molecular Biology
- PCR Supplies
- Pipets, Pipet tips & Pipettors
- Proteins
- Public Safety
- Safety & Apparel
- Safety Supplies
- Signs - Labels - Tapes
- Supplies
- Syneos
- Thermometers & Hydrometers
- Tissue Culture
- Uncategorized items
- Winery & Brewery - Coming Soon!
- X-ray
© 2014 Andwin Scientific